Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IMC-001 by Suzhou Immunofoco Biotechnology for Liver Cancer: Likelihood of Approval
IMC-001 is under clinical development by Suzhou Immunofoco Biotechnology and currently in Phase I for Liver Cancer. According to GlobalData,...